Today, December 4, 2025, an extraordinary general meeting was held in INIFY Laboratories AB, reg. no. 559345-4431 (the "Company"). At the meeting, 66,655,976 shares were represented, corresponding to 84.5 per […]

Stockholm – November 12, 2025 – Inify Laboratories AB (publ), a unique laboratory service that provides cancer diagnostics within pathology, hereby invites its shareholders to Extraordinary General Meeting on December […]

STOCKHOLM – November 12, 2025 – Inify Laboratories AB ("Inify" or the "Company") will in a separate press release call for an extraordinary general meeting (the "EGM") to be held […]

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting on May 20, 2025. A total of 44,461,934 shares were represented at the Annual General Meeting, corresponding […]

Stockholm – April 16, 2025 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May […]

Today, December 6, 2024, INIFY Laboratories AB, org. no. 559345-4431 (the "Company") held an extraordinary general meeting. A total of 28,168,336 shares were represented at the general meeting, which corresponds […]

STOCKHOLM – November 15, 2024 – reference is made to the stock exchange announcement made by Inify Laboratories AB (“Inify” or the “Company”) on 23 October 2024 regarding expansion to […]

Stockholm – November 15, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Extraordinary General Meeting on December […]

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting at the company's premises on May 14, 2024. A total of 30,133,104 shares were represented at the […]

Stockholm – April 11, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May […]